Cancer Drug Appears to Help With Aggressive MS
...to be in the August print issue. Cyclophosphamide has been used in combatting a number of cancers, including lymphomas, multiple myeloma, leukemia, mycosis fungoides, neuroblastoma, ovarian carcinoma, retinoblastoma and breast cancer. The drug affects the function of immune cells known as T and B cells. ...Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
...altrials.gov . About Cutaneous T-cell Lymphoma The cutaneous T-cells lymphomas are comprised of a number of non-Hodgkins T-cell lymphomas, including mycosis fungoides and Sezary syndrome, which have their primary manifestations in the skin. According to the Lymphoma Research Foundation, CTCL comprises abou...Genmab Amends HuMax-CD4 Pivotal Study in CTCL
...f HuMax-CD4(R) (zanolimumab) to treat refractory cutaneous T-cell lymphoma (CTCL) patients. The study which previously only included patients with the mycosis Fungoides (MF) form of CTCL has been expanded to include patients with Sezary Syndrome as well. Furthermore, due to higher response rates observed at ...